CLINICAL TRIALS PROFILE FOR SEROQUEL
✉ Email this page to a colleague
All Clinical Trials for SEROQUEL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00034905 ↗ | A Comparison of Seroquel vs. Risperidone in Schizophrenia | Completed | AstraZeneca | Phase 4 | 2001-07-01 | The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks. |
| NCT00043849 ↗ | Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) | Completed | National Institute on Aging (NIA) | Phase 4 | 2002-07-01 | The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia [PDD] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism. |
| NCT00044655 ↗ | Switching Medication to Treat Schizophrenia | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2001-07-01 | This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia. |
| NCT00044655 ↗ | Switching Medication to Treat Schizophrenia | Completed | Icahn School of Medicine at Mount Sinai | Phase 4 | 2001-07-01 | This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia. |
| NCT00048802 ↗ | Treatment and Outcome of Early Onset Bipolar Disorder | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 2002-08-01 | This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder. |
| NCT00048802 ↗ | Treatment and Outcome of Early Onset Bipolar Disorder | Completed | Northwell Health | Phase 4 | 2002-08-01 | This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder. |
| NCT00060489 ↗ | Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression | Completed | AstraZeneca | Phase 3 | 2002-09-01 | The purpose of this study is to evaluate the efficacy and safety of quetiapine in the treatment of a major depressive episode in patients with bipolar disorder. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SEROQUEL
Condition Name
Clinical Trial Locations for SEROQUEL
Trials by Country
Clinical Trial Progress for SEROQUEL
Clinical Trial Phase
Clinical Trial Sponsors for SEROQUEL
Sponsor Name
